2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- exhibits a diverse range of bioactivities, notably inhibiting multiple kinases such as cyclin-dependent kinases (CDK1, CDK5), protein kinase A (PKA), protein kinase G (PKG), glycogen synthase kinase-3 beta (GSK-3β), and casein kinase I (CK1). Specifically, it demonstrates potent inhibition of human GSK-3β with an IC50 of 2000.0 nM and of PIM1 kinase with an IC50 of 1000.0 nM. The compound also displays significant cytotoxicity against various cell lines, including mouse LMM3 cells (IC50 of 9300.0 nM), human MCF7 cells (IC50 of 24000.0 nM), and mouse HT22 cells (IC50 of 9300.0 nM). Additionally, it inhibits rat recombinant GST-tagged DYRK1A (IC50 of 330.0 nM) and human recombinant GST-tagged CLK1 (IC50 of 220.0 nM).
2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- shows strong antimalarial activity against Plasmodium falciparum D6 and W2 strains, with IC50 values ranging from 11,000 to 14,000 nM. It also demonstrates antimicrobial activity against Cryptococcus neoformans, antitubercular activity against Mycobacterium tuberculosis H37Rv (MIC90 of 111,100 nM), and antimicrobial activity against Leishmania donovani, showing selectivity over mammalian cells. Its potential therapeutic specificity is notable, given its selective toxicity toward microbial versus mammalian cells.
In addition to these activities, 2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- inhibits various cytochrome P450 enzymes, indicating it could modulate drug metabolism. Its inhibitory effects are moderate to strong on CYP1A1, CYP1A2, and CYP3A4, and weaker against CYP1B1, CYP2D6, CYP2C9, and CYP2C19. Furthermore, it exhibits antibiofilm activity against Mycobacterium smegmatis mc2 155 with an IC50 of 22,700.0 nM for inhibiting biofilm formation, and it can disperse preformed biofilms, though at higher concentrations (EC50 > 50,000.0 nM). Overall, 2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- presents a multi-targeted therapeutic potential through its myriad bioactivities..
Note: Summary generated by AI. Data source: ChEMBL 